Durable response rate as an endpoint in cancer immunotherapy: insights from oncolytic virus clinical trials | Journal for ImmunoTherapy of Cancer | Full Text
Objective response rate assessment in oncology: Current situation and future expectations
Frontiers | Investigation of the efficacy and safety of cryoablation and intra-arterial PD-1 inhibitor in patients with advanced disease not responding to checkpoint inhibitors: An exploratory study
Clinical trial end points relevant to patients and society for rare cancers | Semantic Scholar
Objective response rate is a possible surrogate endpoint for survival in patients with advanced, recurrent ovarian cancer - ScienceDirect
Starting with higher-dose prednisone boosts 1-year renal response in lupus nephritis
Abbreviations: CR, complete response; ORR, objective response rate; PR,... | Download Scientific Diagram
Overall vs. Progression-Free Survival, Response Rates: Oncology Terminology 101 (by Oster Oncology) - YouTube
Bortezomib-Based Therapy for Newly Diagnosed Mantle-Cell Lymphoma | NEJM
Physical exercise during neoadjuvant chemotherapy for breast cancer as a mean to increase pathological complete response rates: Trial protocol of the randomized Neo-ACT trial | PLOS ONE
KAZIA PRESENTS FURTHER PAXALISIB AND CANTRIXIL DATA AT AACR, REINFORCING POSITIVE EFFICACY SIGNALS FOR BOTH DRUGS
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Use of Clinical Trials in Expanding Treatment for Ovarian Cancer - ppt download
Response Rate Definition | The Online Advertising Guide
Durable response rate as an endpoint in cancer immunotherapy: insights from oncolytic virus clinical trials | Journal for ImmunoTherapy of Cancer | Full Text
Esophageal adenocarcinoma with any component of signet ring cells portends poor prognosis and response to neoadjuvant therapy - ScienceDirect
Analysis of duration of response in oncology trials. | Semantic Scholar
Relationship Between Progression‐Free Survival, Objective Response Rate, and Overall Survival in Clinical Trials of PD‐1/PD‐L1 Immune Checkpoint Blockade: A Meta‐Analysis - Ye - 2020 - Clinical Pharmacology & Therapeutics - Wiley Online
Immunotherapy 101 - BioCanRx
Clinical Trial Endpoints for Oncology Studies
The overall response rate | Download Table
Iovance Biotherapeutics: The Frontier Of Novel Cancer Treatment (NASDAQ:IOVA) | Seeking Alpha
Study Results | ZYNLONTA® (loncastuximab tesirine-lpyl) Patient Site
Best tumor response and overall response rate (ORR) by disease site (n... | Download Table
